FDA Drug Approval Marks a First for a Disease — But It’s Not Autism

Frank Vinluan / medcitynews - Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence.The post …

AI Summary: The FDA has granted traditional approval to leucovorin for cerebral folate deficiency, formalizing a decades‑old generic’s role in a rare metabolic disorder. The decision comes amid earlier agency notes that evidence for autism benefit was weak and debate over expanding use without fresh trial data — cue the policy hot takes.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #drugdevelopment #fda #autism

FDA clears 1st oral pill for plaque psoriasis

2 months / beckershospitalreview / Ella Jeffries

FDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potential

2 months / endpoints / Max Gelman

Court Lets Perplexity AI Shopping Bots Stay Active on Amazon

2 months / winbuzzer / Markus Kasanmascheff

Clinicians divided amid growing demand for unproven autism drug

2 months / beckershospitalreview / Mariah Taylor

FDA Drug Approval Marks a First for a Disease — But It’s Not Autism

2 months / medcitynews / Frank Vinluan

FDA finds little evidence that a generic drug can help people with autism